Our approach | Artificial Intelligence-based technology | SOM Biotech

DRUG REPURPOSING

Our drug repurposing activities focus on orphan diseases with high unmet medical needs, high potential market values and high regulatory and IP protection. Drug repurposing significantly lowers drug development costs, decreases development time and represents a growing market, currently estimated at USD 317 billion..

Chemicalstructure

List of drugs for the indication

Identification of drugs for an indication

Drug

List of new indications for the drug

Identification of new indications for a drug

Identification of new indications for a drug

List of new indications for the drug

Drug

Identification of drugs for an indication

Chemicalstructure

List of drugs for the indication

Identification of new indications for a drug

Drug

List of new indications for the drug

Learn how we can apply it for your company

You can find articles about SOM^AI-PRO published in Yahoo news, MarketWatch, Financial content. ONE NEWS SAN FRANCISCO.